Companies' tests used in 'superbug' scope cleaning flawed: FDA Print E-mail
Written by Toni Clarke | Reuters   
Friday, 06 March 2015 15:53

Manufacturers' tests of procedures to clean medical scopes linked with "superbug" outbreaks contained flaws that render their cleaning instructions unreliable, according to a senior official with the U.S. Food and Drug Administration.

The scopes were linked to the exposure of 179 patients to drug-resistant bacteria at UCLA's Ronald Reagan Medical Center in Los Angeles and may have contributed to two deaths. Those incidents were announced last month.

In early 2014, following a superbug outbreak at a hospital in Illinois, the FDA asked Fujifilm Holdings Corp, Olympus Corp and Pentax, which make the devices, to submit their test results for review, Dr. Stephen Ostroff, the agency's chief scientist, said in an interview.

Read More>>
Med identity theft continues to rise Print E-mail
Written by Florida Health Industry Week in Review   
Tuesday, 03 March 2015 19:29

What Happened
In a February 23, 2015 post by Katie Dvorak on FierceHealthIT:
Medical identity theft incidents rose more than 20 percent in fiscal year 2014 compared to the year prior, according to a recently released survey by the Ponemon Institute.

Why it Matters
Ms. Dvorak Writes:
And issues surrounding safety of health data show no signs of slowing. This year has already seen one of the biggest incidents in the industry's history when personal information for roughly 80 million individuals was compromised after hackers broke into a database for Anthem Inc., the nation's second-largest health insurance company.

Read more in the current issue of Week in Review HERE.

Last Updated on Tuesday, 03 March 2015 19:35
Innovations in Health Insurance Design Print E-mail
Written by The Incidental Economist | Michael Chernew and Aaron Schwartz   
Friday, 27 February 2015 19:39

Recently, there has been much discussion of innovations in benefit design, including on this blog, where there was a recent post about a split benefit design. Given the range of proposed options it is useful to revisit the connection between benefit design and theory.
The goal of optimal insurance design is to maximize societal welfare, which consists of two elements. First, an optimal plan steers beneficiaries toward high value services, minimizing moral hazard. Second, an optimal plan provides protection against risk, ensuring that beneficiaries can expect to experience relatively similar welfare across a range of possible life outcomes (i.e. in sickness and in health).
The motivation for cost sharing in standard economic models is to balance these sometimes competing objectives.

Read More>>
MD Anderson doctor planning online petition against cancer drug costs Print E-mail
Written by Florida Health Industry Week in Review   
Tuesday, 24 February 2015 19:53

What Happened
On 2-16-15, Todd Ackerman of the Houston Chronicle writes:

Dr. Hagop Kantarjian, chairman of M.D. Anderson Cancer Center's leukemia department, is planning an online campaign to collect the signatures of 1 million cancer patients affected by high drug prices.

The Houston architect of a doctor-led campaign against the high cost of new cancer drugs, frustrated at the effort's ineffectiveness, is about to call on patients to ratchet up the pressure.
Why It Matters
Can an Arab Spring-like "revolution" take down the mighty Pharma empire? Tyrants everywhere should fear social media.

Read More in this week's issue of Week in Review HERE.

Last Updated on Tuesday, 24 February 2015 20:00
Sponsor Showcase Print E-mail
Written by Sponsor   
Wednesday, 25 February 2015 00:00
gsk fhi 285x237 2015
Last Updated on Wednesday, 25 February 2015 15:58

Website design, development, and hosting provided by